Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Age of transfused blood in critically ill adults.

The New England journal of medicine·2015

Same author

Effects of red-cell storage duration on patients undergoing cardiac surgery.

The New England journal of medicine·2015

Same author

Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial.

JAMA·2012

Same author

Addressing the risk of bacterial contamination of platelets within the United States: a history to help illuminate the future.

Transfusion·2012

Same author

The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshop.

Transfusion·2012

Same author

Clinical review: Canadian National Advisory Committee on Blood and Blood Products--Massive transfusion consensus conference 2011: report of the panel.

Critical care (London, England)·2011

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation

Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation

Published on: May 20, 2021

Why implement universal leukoreduction?

Wafaa Y Bassuni¹, Morris A Blajchman, May A Al-Moshary

¹Central Laboratory and Transfusion Services, King Fahad Medical City, Riyadh, Saudi Arabia. wafaa_bassuni@hotmail.com

Hematology/Oncology and Stem Cell Therapy

|January 13, 2010

Summary

Universal leukoreduction (ULR) significantly enhances blood transfusion safety by removing leukocytes, reducing adverse reactions and transmission risks. Despite cost concerns, international adoption demonstrates ULR

More Related Videos

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Rapid Magnetic-microbead Method for Efficient Purification of Low-density Neutrophils

Rapid Magnetic-microbead Method for Efficient Purification of Low-density Neutrophils

Published on: November 11, 2025

Related Experiment Videos

Last Updated: Jun 17, 2026

Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation

Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation

Published on: May 20, 2021

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Rapid Magnetic-microbead Method for Efficient Purification of Low-density Neutrophils

Rapid Magnetic-microbead Method for Efficient Purification of Low-density Neutrophils

Published on: November 11, 2025

Area of Science:

Transfusion Medicine
Hematology
Immunology

Background:

Leukocytes in blood components have been overlooked in transfusion safety.
Leukocyte reduction (leukoreduction) techniques offer significant clinical benefits.

Purpose of the Study:

To highlight the clinical benefits of leukoreduction in allogeneic blood transfusions.
To discuss the international adoption and barriers to universal leukoreduction (ULR).

Main Methods:

Review of clinical outcomes associated with leukoreduction.
Analysis of international policies regarding universal leukoreduction.

Main Results:

Leukoreduction reduces febrile transfusion reactions, cytomegalovirus transmission, and alloimmune platelet refractoriness.
It may decrease risks of variant Creutzfeldt-Jakob disease transmission and improve recipient mortality and organ function, especially in cardiac surgery.
Nineteen countries have adopted ULR, with cost being a primary barrier in others.

Conclusions:

Universal leukoreduction (ULR) is a critical advancement in transfusion safety.
ULR demonstrably improves patient outcomes and reduces transfusion-related risks.
Wider implementation of ULR is supported by international experience and clinical evidence.